Immucor seeks FDA nod for blood bank technology:
This article was originally published in Clinica
Executive Summary
Immucor, a provider of automated instrument-reagent systems to the blood transfusion industry, has submitted a 510(k) marketing application to the US FDA for its Galileo instrument. The product is a high-throughput, highly automated blood bank system. It was launched in Europe in mid 2002. Edward Gallup, the Norcross, Georgia firm's chairman and CEO, said that "at the end of November 2003, the company had 93 placements."